SEC Tracker
Get the app

Dare Bioscience DARE

Dare announces special meeting on Nov 10

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Special meeting on Nov 10, 2026
  2. Proposal 1: approve future stock issuance from warrants
  3. Proposal 2: approve adjournment to solicit more votes

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Dare Bioscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lunai Bioworks LNAI public float $21M, Dec 31, 2025
  2. Imunon IMNN public float $21M, Jun 30, 2025
  3. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  4. Fibrogen FGEN public float $21M, Jun 30, 2025
  5. Aptose Biosciences APTOF public float $22M, Jun 28, 2025